The Department of Health and Human Services has announced more than $500 million in awards to support companies as they
Artificial intelligence is taking the world by storm, and its potential use cases are seemingly endless within the federal government,
The Department of Health and Human Services is investing more than $1.4 billion in developing next-generation vaccines and therapeutics against
Emergent BioSolutions (NYSE: EBS) will further develop a licensed drug against Ebola under a potential 10-year, $704 million contract from
The Department of Health and Human Services’ Biomedical Advanced Research and Development Authority has begun seeking proposals for the second
A Department of Health and Human Services office has begun seeking proposals for a potential 10-year, $10 billion multiple-purpose acquisition
The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services is soliciting comments on a
The Biden administration is supporting collaboration between Johnson & Johnson (NYSE: JNJ) and Merck (NYSE: MRK) to produce more COVID-19
The departments of Health and Human Services and Defense have earmarked $3.65 billion to buy 100 million additional doses of…
Regeneron Pharmaceuticals (Nasdaq: REGN) will supply an additional 1.25M treatment courses of an antibody cocktail composed of casirivimab and imdevimab
